Hoshi et al istration and 3-days withdrawal/week plus CDDP:80mg/m2 day, q 3 weeks, andregimenB was 5'-DFUR: 1 ,400mg/m2/day, 4-days administration and 10-days withdrawal/every 2 weeks plus CDDP: 80mg/m2 day, day 5, q 4 weeks. The overall response rate for Regimen A was 40% (95% CI, These 10 items were recorded by the patients for 2-4 weeks in five grades by a combination of the analog scale and category scale method. Moreover, the analog scale, 10 cm in length about "feeling" was also checked at the same time. By chance we could compare the change in the 10 items in the QOLquestionnaires between Regimen A and Regimen B. A remarkable difference between Regimen A and Regimen B was recognized for appetite, general feeling, fatigue, expectations of treatment and the analog scale about "feeling" based on the followup data of the QOLquestionnaire. As a result, from the point of QOL, RegimenB is considered to be muchbetter than RegimenA. In the near future, Leucovorin plus 5-FU and CPT-1 1 are expected to be used for advanced gastric cancers.
association with friends and colleagues, anxiety concerning the disease, expectations of treatment and daily life activities.
These 10 items were recorded by the patients for 2-4 weeks in five grades by a combination of the analog scale and category scale method. Moreover, the analog scale, 10 cm in length about "feeling" was also checked at the same time. By chance we could compare the change in the 10 items in the QOLquestionnaires between Regimen A and Regimen B. A remarkable difference between Regimen A and Regimen B was recognized for appetite, general feeling, fatigue, expectations of treatment and the analog scale about "feeling" based on the followup data of the QOLquestionnaire. As a result, from the point of QOL, RegimenB is considered to be muchbetter than RegimenA. In the near future, Leucovorin plus 5-FU and CPT-1 1 are expected to be used for advanced gastric cancers. Someexperimental evidence has revealed that the increase of tumor blood flow was observed in all tumors arising from various organs and various types of histology (2, 3) and that the chemotherapeutic inhibitory effects on tumor growth in the liver and the peritoneum were enhanced under AII hypertension (4, 5) . By comparison of Computed Tomography (CT) values in region of interests (ROIs) using dynamic CT, the enhancement of contrast media in the tumorarea was clearly elevated under A II hypertension (6) . The results of a cooperative, randomized, controlled trial for advanced gastric carcinoma showeda significant enhancement in the anti-cancer effects in the IHC-treated group compared with that of the non-IHC group which received ordinary iv treatment under normotension (7) . The frequency and grade of the side effects of the anti-cancer drugs were not statistically different between the IHC and non-IHC groups. Moreover, pathohistological effects on the tumor tissues were evidently augmented in the gastrectomy-receiving patients of the IHC grpup. According to the criteria of the General Rules for the Stomach Cancer Study, one case of grade 3, 2 of grade 2, 3 of lb, and 2 of 1a were obtained in the IHC group, while one of lb, 3 of la, and 2 of zero were obtained in the non-IHC group (8).
The procedure of IHC has been previously described elsewhere (9).
Therewere someaccompanying symptoms such as a sense of chest oppression and headache whenthe blood pressure was only elevated, but they were not so severe that the IHC couldnot be performed in nearly all the cases. But, careful attention to control the blood pressure values must be paid to avoid excess 
